Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04240392 · ClinicalTrials.gov registry record · NA

Treatment of Pregnant Women With OUD

A NA study of Opioid Use Disorder, sponsored by Yale University.

Completed
Registry status
NA
Development phase
230
Enrollment target
11
Study locations

NCT04240392 is a NA study of Opioid Use Disorder that has completed, run by Yale University. The registered enrollment target is 230 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 11 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04240392, a NA study of Opioid Use Disorder, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
230 participants
Enrollment target
11
Study locations

Study Summary

The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

Conditions Studied

Interventions

  • BEHAVIORAL Collaborative Care (CC)
  • BEHAVIORAL Extension for Community Healthcare Outcomes (ECHO)

Study Locations (11)

Connecticut

  • Hartford Hospital - Hartford
  • Hospital of Central CT - New Britain
  • Yale New Haven Hospital Maternal Fetal Medicine Unit - New Haven
  • Yale New Haven Hospital Women's Center/Hill Health Center - New Haven
  • Coastal ObGyn & Midwifery - New London
  • OB Gyn Services PC - Norwich

Massachusetts

  • Essex County ObGyn - Beverly
  • Beth Israel Deaconess Medical Center - Boston
  • AFA Obstetrics & Gynecology - Concord
  • Women's Health, Lowell General Hospital - Lowell
  • Wesson's Women's Clinic UMASS Baystate - Springfield

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2020-06-18
Est. Completion 2024-10-10
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04240392

The ClinicalTrials.gov registry entry for NCT04240392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Care (CC) is the first listed.

NCT04240392 reports 11 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04240392 about?

NCT04240392 is a clinical study titled "Treatment of Pregnant Women With OUD". The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

What is the current status of trial NCT04240392?

This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2020-06-18. Estimated completion is 2024-10-10.

What conditions does trial NCT04240392 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT04240392?

The interventions under investigation include: Collaborative Care (CC) (BEHAVIORAL), Extension for Community Healthcare Outcomes (ECHO) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04240392?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04240392 being conducted?

This trial has 11 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.